FindMyKOL
Clinical trialNCT01597089TerminatedObservational

Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples

NCT01597089 is an observational study sponsored by National Institutes of Health Clinical Center (CC). As of 21 Nov 2026, it was terminated. It studies Respiratory Viruses. The registry lists an enrollment of 35 participants at 1 site in 1 country. The registry lists a start date of 1 Sept 2012.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01597089
FieldValue
Registry IDNCT01597089
StatusTerminated
Study typeObservational study
Lead sponsorNational Institutes of Health Clinical Center (CC)
Enrollment35
Registered sites1
Countries1
ConditionsRespiratory Viruses
Start1 Sept 2012
Study completion1 May 2018
Last update posted3 May 2018

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Background: \- Bronchoalveolar lavage (BAL) is a procedure where a tube is passed through the mouth or nose into the lungs. Fluid is squirted through the tube into a part of the lung and then collected for examination. It is used to detect respiratory viruses. BAL is a relatively invasive procedure, and researchers want to test the accuracy of other procedures that do not involve collecting fluid from the lungs. The nasopharynx is the area of the upper throat that lies behind the nose. Researchers want to see if a swab taken from this area is as accurate as a BAL sample. Objectives: \- To see if a nasopharynx swab can be used to detect respiratory viruses as well as BAL samples. Eligibility: \- Individuals at least 12 years of age who will have a bronchoscopy to collect a BAL sample to test for respiratory viruses. Design: * Participants will be screened with a physical exam and medical history. * Participants will have a BAL sample collected. * Participants will then have a nasopharynx swab. The swab will be inserted into the nose, left in place for up to 10 seconds, and then removed

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Daniel S Chertow, M.D.

    National Institutes of Health Clinical Center (CC)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Maryland, United States1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 1 siteMD1DelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01597089

Each answer restates registry values shown on this page.

What is NCT01597089?

NCT01597089 is an observational study sponsored by National Institutes of Health Clinical Center (CC). It studies Respiratory Viruses.

Who leads NCT01597089?

The registry names Daniel S Chertow, M.D. (principal investigator, National Institutes of Health Clinical Center (CC)) as the overall official.

Where does NCT01597089 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01597089 end?

The registry lists a study completion date of 1 May 2018. The sponsor last updated the record on 3 May 2018.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.